Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Molecular Diagnostic Techniques | 3 | 2020 | 602 | 0.920 |
Why?
|
Pathology, Molecular | 4 | 2017 | 326 | 0.810 |
Why?
|
Laboratories, Hospital | 2 | 2020 | 194 | 0.700 |
Why?
|
Colonic Neoplasms | 17 | 2020 | 2541 | 0.690 |
Why?
|
Clinical Laboratory Techniques | 2 | 2020 | 738 | 0.520 |
Why?
|
Pancreatic Cyst | 1 | 2017 | 368 | 0.460 |
Why?
|
Fusion Proteins, bcr-abl | 1 | 2013 | 434 | 0.400 |
Why?
|
Genetic Diseases, Inborn | 1 | 2016 | 587 | 0.400 |
Why?
|
Telomere | 1 | 2017 | 910 | 0.400 |
Why?
|
Nervous System Diseases | 1 | 2020 | 1622 | 0.350 |
Why?
|
Colitis | 4 | 2020 | 1170 | 0.260 |
Why?
|
Gene Expression Regulation, Neoplastic | 12 | 2020 | 8428 | 0.250 |
Why?
|
Pancreatic Neoplasms | 2 | 2017 | 5256 | 0.210 |
Why?
|
Azoxymethane | 7 | 2011 | 36 | 0.200 |
Why?
|
Transcription, Genetic | 2 | 2013 | 7722 | 0.190 |
Why?
|
Ursodeoxycholic Acid | 3 | 2008 | 72 | 0.190 |
Why?
|
Genetic Variation | 1 | 2016 | 6544 | 0.190 |
Why?
|
Precancerous Conditions | 4 | 2012 | 975 | 0.180 |
Why?
|
Cyclooxygenase 2 | 5 | 2009 | 611 | 0.180 |
Why?
|
Cord Blood Stem Cell Transplantation | 2 | 2013 | 314 | 0.170 |
Why?
|
MicroRNAs | 4 | 2020 | 3752 | 0.170 |
Why?
|
Utilization Review | 1 | 2020 | 392 | 0.160 |
Why?
|
Adenomatous Polyposis Coli Protein | 1 | 2019 | 188 | 0.160 |
Why?
|
Cost Control | 1 | 2020 | 624 | 0.150 |
Why?
|
Neoplasms | 3 | 2016 | 21683 | 0.150 |
Why?
|
Losartan | 1 | 2019 | 299 | 0.150 |
Why?
|
Genes, ras | 4 | 2013 | 690 | 0.150 |
Why?
|
Chemokine CXCL2 | 1 | 2016 | 111 | 0.140 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2020 | 397 | 0.140 |
Why?
|
Receptors, Calcitriol | 2 | 2019 | 350 | 0.140 |
Why?
|
ras Proteins | 4 | 2014 | 1060 | 0.140 |
Why?
|
Transplantation Conditioning | 3 | 2013 | 1598 | 0.130 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 2 | 2017 | 890 | 0.130 |
Why?
|
Proto-Oncogene Proteins | 5 | 2014 | 4554 | 0.130 |
Why?
|
Mitogen-Activated Protein Kinase 7 | 1 | 2014 | 66 | 0.120 |
Why?
|
Transforming Growth Factor alpha | 2 | 2016 | 135 | 0.120 |
Why?
|
Receptor Cross-Talk | 1 | 2014 | 119 | 0.120 |
Why?
|
DNA Mutational Analysis | 4 | 2016 | 4186 | 0.120 |
Why?
|
RNA | 1 | 2004 | 2749 | 0.120 |
Why?
|
Sarcoma, Myeloid | 1 | 2014 | 59 | 0.120 |
Why?
|
Oncogene Proteins v-myb | 1 | 2013 | 26 | 0.120 |
Why?
|
Asymptomatic Diseases | 1 | 2016 | 551 | 0.110 |
Why?
|
Cytogenetic Analysis | 1 | 2014 | 295 | 0.110 |
Why?
|
Indazoles | 1 | 2015 | 289 | 0.110 |
Why?
|
Paraffin Embedding | 1 | 2014 | 299 | 0.110 |
Why?
|
Colon | 4 | 2014 | 1772 | 0.110 |
Why?
|
Dextran Sulfate | 2 | 2011 | 236 | 0.110 |
Why?
|
Microsatellite Instability | 1 | 2016 | 684 | 0.110 |
Why?
|
Insulin Receptor Substrate Proteins | 1 | 2014 | 563 | 0.110 |
Why?
|
Telomerase | 1 | 2017 | 730 | 0.110 |
Why?
|
Proto-Oncogene Proteins c-pim-1 | 1 | 2012 | 34 | 0.110 |
Why?
|
Receptors, CXCR4 | 1 | 2016 | 726 | 0.100 |
Why?
|
Colitis, Ulcerative | 3 | 2013 | 1912 | 0.100 |
Why?
|
Iodine Radioisotopes | 1 | 2015 | 1032 | 0.100 |
Why?
|
Microarray Analysis | 1 | 2014 | 767 | 0.100 |
Why?
|
Paxillin | 1 | 2010 | 86 | 0.100 |
Why?
|
PTEN Phosphohydrolase | 1 | 2017 | 1142 | 0.100 |
Why?
|
CCAAT-Enhancer-Binding Protein-beta | 2 | 2008 | 103 | 0.100 |
Why?
|
Lymphoma, T-Cell | 1 | 2013 | 299 | 0.100 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2013 | 648 | 0.090 |
Why?
|
Adenocarcinoma, Bronchiolo-Alveolar | 1 | 2010 | 91 | 0.090 |
Why?
|
DNA Copy Number Variations | 2 | 2016 | 1941 | 0.090 |
Why?
|
Proto-Oncogenes | 1 | 2011 | 321 | 0.090 |
Why?
|
Cholecalciferol | 2 | 2007 | 537 | 0.090 |
Why?
|
Peripheral Blood Stem Cell Transplantation | 1 | 2011 | 272 | 0.090 |
Why?
|
Incidental Findings | 1 | 2015 | 689 | 0.090 |
Why?
|
Renin-Angiotensin System | 1 | 2014 | 759 | 0.090 |
Why?
|
Gene Expression Profiling | 2 | 2013 | 9438 | 0.090 |
Why?
|
Carcinoma, Papillary | 1 | 2015 | 783 | 0.090 |
Why?
|
Haplotypes | 2 | 2013 | 2779 | 0.090 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2014 | 1157 | 0.080 |
Why?
|
Education, Medical, Undergraduate | 1 | 2018 | 1008 | 0.080 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2013 | 689 | 0.080 |
Why?
|
Insurance Coverage | 1 | 2020 | 1901 | 0.080 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 5 | 2014 | 1692 | 0.080 |
Why?
|
Imidazoles | 1 | 2015 | 1206 | 0.080 |
Why?
|
Benzimidazoles | 1 | 2013 | 850 | 0.080 |
Why?
|
Tumor Suppressor Protein p53 | 2 | 2017 | 2948 | 0.080 |
Why?
|
Antibodies, Neoplasm | 1 | 2009 | 286 | 0.080 |
Why?
|
Cell Transformation, Neoplastic | 4 | 2014 | 2942 | 0.080 |
Why?
|
Adenoma | 2 | 2010 | 2174 | 0.080 |
Why?
|
Chromosome Aberrations | 1 | 2014 | 1813 | 0.080 |
Why?
|
Humans | 34 | 2020 | 744343 | 0.070 |
Why?
|
Down-Regulation | 4 | 2020 | 3002 | 0.070 |
Why?
|
Transplantation Chimera | 1 | 2009 | 612 | 0.070 |
Why?
|
Mutation | 7 | 2017 | 29786 | 0.070 |
Why?
|
Reproducibility of Results | 2 | 2016 | 19905 | 0.070 |
Why?
|
Stromal Cells | 1 | 2012 | 1355 | 0.070 |
Why?
|
High-Throughput Nucleotide Sequencing | 2 | 2016 | 3597 | 0.070 |
Why?
|
Prognosis | 3 | 2016 | 29063 | 0.070 |
Why?
|
Lymphoma, B-Cell | 1 | 2013 | 931 | 0.070 |
Why?
|
Pancreatitis | 1 | 2013 | 1092 | 0.070 |
Why?
|
Genes, Tumor Suppressor | 1 | 2011 | 1097 | 0.070 |
Why?
|
HSP70 Heat-Shock Proteins | 1 | 2008 | 404 | 0.070 |
Why?
|
Curriculum | 2 | 2018 | 3605 | 0.070 |
Why?
|
Disease Models, Animal | 5 | 2019 | 18029 | 0.070 |
Why?
|
Lymphoma | 2 | 2012 | 1877 | 0.070 |
Why?
|
Genetic Heterogeneity | 1 | 2009 | 733 | 0.070 |
Why?
|
Vitamin D | 1 | 2019 | 3223 | 0.070 |
Why?
|
Adenoma, Villous | 1 | 2005 | 15 | 0.060 |
Why?
|
DNA-Binding Proteins | 2 | 2013 | 9648 | 0.060 |
Why?
|
Colonic Polyps | 1 | 2010 | 542 | 0.060 |
Why?
|
Genomics | 2 | 2018 | 5720 | 0.060 |
Why?
|
Cyclin D1 | 2 | 2007 | 463 | 0.060 |
Why?
|
Radiopharmaceuticals | 1 | 2015 | 2645 | 0.060 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2011 | 828 | 0.060 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2008 | 697 | 0.060 |
Why?
|
Medical Oncology | 1 | 2016 | 2265 | 0.060 |
Why?
|
Graft Survival | 2 | 2013 | 3737 | 0.060 |
Why?
|
Hepacivirus | 1 | 2011 | 1379 | 0.060 |
Why?
|
Combined Modality Therapy | 1 | 2016 | 8642 | 0.060 |
Why?
|
HIV | 1 | 2011 | 1604 | 0.060 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 4751 | 0.060 |
Why?
|
Up-Regulation | 4 | 2020 | 4217 | 0.060 |
Why?
|
Cost-Benefit Analysis | 1 | 2016 | 5391 | 0.060 |
Why?
|
Hematopoiesis | 1 | 2013 | 2072 | 0.060 |
Why?
|
Antineoplastic Agents | 3 | 2017 | 13695 | 0.060 |
Why?
|
RNA, Viral | 1 | 2011 | 2902 | 0.050 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2013 | 1634 | 0.050 |
Why?
|
Viral Load | 1 | 2011 | 3299 | 0.050 |
Why?
|
Microsatellite Repeats | 1 | 2005 | 802 | 0.050 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 1 | 2003 | 329 | 0.050 |
Why?
|
Proto-Oncogene Proteins c-bcl-6 | 2 | 2013 | 193 | 0.050 |
Why?
|
Early Detection of Cancer | 1 | 2016 | 3086 | 0.050 |
Why?
|
Repressor Proteins | 1 | 2013 | 3023 | 0.050 |
Why?
|
Mice | 12 | 2020 | 81183 | 0.050 |
Why?
|
Graft vs Host Disease | 2 | 2011 | 2957 | 0.050 |
Why?
|
Autoimmune Diseases | 1 | 2013 | 2133 | 0.050 |
Why?
|
Thyroid Neoplasms | 1 | 2015 | 2282 | 0.050 |
Why?
|
Protein Kinase Inhibitors | 2 | 2017 | 5535 | 0.050 |
Why?
|
Oligonucleotide Array Sequence Analysis | 2 | 2013 | 3920 | 0.050 |
Why?
|
HCT116 Cells | 2 | 2012 | 408 | 0.050 |
Why?
|
Reference Standards | 1 | 2004 | 1025 | 0.050 |
Why?
|
Clinical Trials as Topic | 1 | 2016 | 7913 | 0.050 |
Why?
|
Karyopherins | 1 | 2020 | 137 | 0.040 |
Why?
|
Sensitivity and Specificity | 2 | 2013 | 14722 | 0.040 |
Why?
|
Retroviridae | 2 | 2013 | 914 | 0.040 |
Why?
|
Nuclear Proteins | 1 | 2014 | 5853 | 0.040 |
Why?
|
Animals | 16 | 2020 | 168757 | 0.040 |
Why?
|
Lung Neoplasms | 2 | 2017 | 13102 | 0.040 |
Why?
|
Immunohistochemistry | 5 | 2013 | 11366 | 0.040 |
Why?
|
Transplantation, Homologous | 3 | 2013 | 4776 | 0.040 |
Why?
|
Transcription Factors | 3 | 2014 | 12208 | 0.040 |
Why?
|
Isoenzymes | 1 | 2003 | 1726 | 0.040 |
Why?
|
Delivery of Health Care | 1 | 2016 | 5319 | 0.040 |
Why?
|
Neoplasm Proteins | 1 | 2010 | 3703 | 0.040 |
Why?
|
Adenocarcinoma | 3 | 2017 | 6364 | 0.040 |
Why?
|
Cadherins | 1 | 2002 | 907 | 0.040 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2013 | 3523 | 0.040 |
Why?
|
Polymerase Chain Reaction | 2 | 2004 | 6171 | 0.040 |
Why?
|
Mice, Inbred A | 2 | 2007 | 248 | 0.040 |
Why?
|
RNA, Messenger | 5 | 2013 | 13033 | 0.040 |
Why?
|
Inflammation | 2 | 2020 | 10638 | 0.040 |
Why?
|
Cell Line, Tumor | 4 | 2016 | 16689 | 0.040 |
Why?
|
Treatment Outcome | 4 | 2017 | 63114 | 0.040 |
Why?
|
Spiro Compounds | 1 | 2016 | 76 | 0.030 |
Why?
|
Ligands | 2 | 2016 | 3282 | 0.030 |
Why?
|
Phosphatidylinositol 3-Kinases | 2 | 2017 | 2938 | 0.030 |
Why?
|
Angiotensin II Type 1 Receptor Blockers | 1 | 2019 | 451 | 0.030 |
Why?
|
Antibodies, Monoclonal | 2 | 2011 | 9274 | 0.030 |
Why?
|
Blotting, Western | 3 | 2011 | 5179 | 0.030 |
Why?
|
Government Regulation | 1 | 2020 | 522 | 0.030 |
Why?
|
Mice, Knockout | 3 | 2019 | 14557 | 0.030 |
Why?
|
Models, Educational | 1 | 2018 | 377 | 0.030 |
Why?
|
Cyclooxygenase 2 Inhibitors | 2 | 2008 | 320 | 0.030 |
Why?
|
Signal Transduction | 6 | 2016 | 23403 | 0.030 |
Why?
|
Rats, Inbred F344 | 2 | 2008 | 862 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor Receptor-3 | 1 | 2015 | 118 | 0.030 |
Why?
|
Genetic Predisposition to Disease | 1 | 2016 | 17446 | 0.030 |
Why?
|
Problem-Based Learning | 1 | 2018 | 361 | 0.030 |
Why?
|
Costs and Cost Analysis | 1 | 2020 | 1681 | 0.030 |
Why?
|
Interleukin-1beta | 2 | 2012 | 972 | 0.030 |
Why?
|
Intestinal Mucosa | 3 | 2013 | 3036 | 0.030 |
Why?
|
Male | 16 | 2015 | 350118 | 0.030 |
Why?
|
Colorectal Neoplasms | 1 | 2013 | 6773 | 0.030 |
Why?
|
Tissue Fixation | 1 | 2014 | 241 | 0.030 |
Why?
|
Smad4 Protein | 1 | 2013 | 163 | 0.030 |
Why?
|
Diet | 1 | 2011 | 7939 | 0.030 |
Why?
|
Middle Aged | 11 | 2015 | 213383 | 0.030 |
Why?
|
Immunoglobulin Isotypes | 1 | 2013 | 158 | 0.030 |
Why?
|
Formaldehyde | 1 | 2014 | 353 | 0.030 |
Why?
|
Radiation Tolerance | 1 | 2015 | 486 | 0.030 |
Why?
|
DNA Methylation | 2 | 2020 | 4286 | 0.030 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2015 | 730 | 0.030 |
Why?
|
Neoplasms, Experimental | 2 | 2011 | 1276 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2015 | 546 | 0.030 |
Why?
|
Transfection | 2 | 2012 | 5892 | 0.030 |
Why?
|
Lymphocyte Subsets | 1 | 2013 | 315 | 0.030 |
Why?
|
Pharmacogenetics | 1 | 2016 | 675 | 0.030 |
Why?
|
Aged | 9 | 2015 | 163280 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor Receptor-1 | 1 | 2015 | 552 | 0.030 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2009 | 5442 | 0.030 |
Why?
|
Illinois | 1 | 2011 | 119 | 0.020 |
Why?
|
Angiotensin II | 1 | 2014 | 881 | 0.020 |
Why?
|
Genetic Counseling | 1 | 2015 | 600 | 0.020 |
Why?
|
Cell Proliferation | 2 | 2019 | 10481 | 0.020 |
Why?
|
Tumor Cells, Cultured | 1 | 2019 | 6314 | 0.020 |
Why?
|
Mice, Inbred C57BL | 3 | 2019 | 21827 | 0.020 |
Why?
|
Quinazolines | 2 | 2008 | 1356 | 0.020 |
Why?
|
Lymphocyte Count | 1 | 2013 | 793 | 0.020 |
Why?
|
Mucin-6 | 1 | 2010 | 15 | 0.020 |
Why?
|
Vitamins | 1 | 2019 | 1622 | 0.020 |
Why?
|
Adult | 9 | 2015 | 214055 | 0.020 |
Why?
|
Gene Amplification | 1 | 2015 | 1063 | 0.020 |
Why?
|
Rats | 4 | 2011 | 24260 | 0.020 |
Why?
|
Mice, Transgenic | 2 | 2013 | 9734 | 0.020 |
Why?
|
GTPase-Activating Proteins | 1 | 2013 | 498 | 0.020 |
Why?
|
Genes, erbB-1 | 1 | 2010 | 161 | 0.020 |
Why?
|
fms-Like Tyrosine Kinase 3 | 1 | 2013 | 491 | 0.020 |
Why?
|
Female | 12 | 2015 | 380194 | 0.020 |
Why?
|
G1 Phase | 1 | 2011 | 415 | 0.020 |
Why?
|
Apoptosis | 2 | 2019 | 9727 | 0.020 |
Why?
|
Rotation | 1 | 2011 | 523 | 0.020 |
Why?
|
Antigens, CD34 | 1 | 2011 | 657 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2013 | 776 | 0.020 |
Why?
|
Adult Stem Cells | 1 | 2011 | 216 | 0.020 |
Why?
|
DNA, Complementary | 1 | 2013 | 2050 | 0.020 |
Why?
|
Case-Control Studies | 3 | 2013 | 21746 | 0.020 |
Why?
|
Mutagenesis, Insertional | 1 | 2012 | 655 | 0.020 |
Why?
|
Pneumococcal Vaccines | 1 | 2013 | 391 | 0.020 |
Why?
|
Chromosomes, Human, Pair 12 | 1 | 2010 | 462 | 0.020 |
Why?
|
Young Adult | 5 | 2014 | 56430 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2019 | 6489 | 0.020 |
Why?
|
Survival Analysis | 2 | 2012 | 10252 | 0.020 |
Why?
|
Dilatation, Pathologic | 1 | 2010 | 520 | 0.020 |
Why?
|
Coculture Techniques | 1 | 2012 | 1341 | 0.020 |
Why?
|
Cyclin D | 1 | 2008 | 71 | 0.020 |
Why?
|
Cholic Acid | 1 | 2008 | 34 | 0.020 |
Why?
|
Piperidines | 1 | 2016 | 1602 | 0.020 |
Why?
|
Cell Division | 2 | 2007 | 4568 | 0.020 |
Why?
|
In Situ Hybridization | 1 | 2011 | 1950 | 0.020 |
Why?
|
Virus Diseases | 1 | 2013 | 711 | 0.020 |
Why?
|
Hyperplasia | 1 | 2010 | 1185 | 0.020 |
Why?
|
Transcription Factor AP-1 | 1 | 2008 | 317 | 0.020 |
Why?
|
Genetic Markers | 1 | 2013 | 2634 | 0.020 |
Why?
|
Prostatic Neoplasms | 1 | 2009 | 11124 | 0.020 |
Why?
|
Cell Cycle | 1 | 2014 | 2967 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2017 | 6895 | 0.020 |
Why?
|
Gene Dosage | 1 | 2010 | 1252 | 0.020 |
Why?
|
Tacrolimus | 1 | 2009 | 743 | 0.020 |
Why?
|
Remission Induction | 1 | 2011 | 2386 | 0.020 |
Why?
|
Administration, Oral | 1 | 2013 | 3913 | 0.020 |
Why?
|
Cyclins | 1 | 2008 | 603 | 0.020 |
Why?
|
CpG Islands | 1 | 2010 | 1172 | 0.020 |
Why?
|
Chemoprevention | 1 | 2008 | 319 | 0.020 |
Why?
|
Eosinophilia | 1 | 2010 | 541 | 0.020 |
Why?
|
Genetic Association Studies | 1 | 2015 | 2703 | 0.020 |
Why?
|
Students, Medical | 1 | 2018 | 1862 | 0.020 |
Why?
|
Aged, 80 and over | 3 | 2015 | 57776 | 0.020 |
Why?
|
Base Sequence | 2 | 2008 | 12797 | 0.020 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2007 | 625 | 0.020 |
Why?
|
Carcinogens | 1 | 2007 | 466 | 0.020 |
Why?
|
In Situ Hybridization, Fluorescence | 1 | 2010 | 2649 | 0.020 |
Why?
|
Point Mutation | 1 | 2009 | 1623 | 0.010 |
Why?
|
DNA Primers | 1 | 2008 | 2892 | 0.010 |
Why?
|
Transplantation, Heterologous | 1 | 2012 | 2382 | 0.010 |
Why?
|
Chromosomal Instability | 1 | 2005 | 184 | 0.010 |
Why?
|
STAT3 Transcription Factor | 1 | 2008 | 873 | 0.010 |
Why?
|
Receptors, Antigen, T-Cell | 1 | 2013 | 2540 | 0.010 |
Why?
|
Bone Marrow | 1 | 2014 | 2948 | 0.010 |
Why?
|
Genetic Vectors | 1 | 2013 | 3420 | 0.010 |
Why?
|
Translocation, Genetic | 1 | 2009 | 1420 | 0.010 |
Why?
|
Education, Medical, Graduate | 1 | 2016 | 2291 | 0.010 |
Why?
|
Receptors, Androgen | 1 | 2009 | 1058 | 0.010 |
Why?
|
Injections, Intraperitoneal | 1 | 2002 | 425 | 0.010 |
Why?
|
Medicare | 1 | 2020 | 6566 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2017 | 5172 | 0.010 |
Why?
|
Cell Cycle Proteins | 1 | 2013 | 3462 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-myc | 1 | 2007 | 987 | 0.010 |
Why?
|
Immunoglobulin G | 1 | 2013 | 4560 | 0.010 |
Why?
|
beta Catenin | 1 | 2007 | 1059 | 0.010 |
Why?
|
Leukemia | 1 | 2009 | 1511 | 0.010 |
Why?
|
Oncogene Proteins, Fusion | 1 | 2009 | 1581 | 0.010 |
Why?
|
Hematologic Neoplasms | 1 | 2013 | 1832 | 0.010 |
Why?
|
Neoplasm Invasiveness | 1 | 2008 | 3616 | 0.010 |
Why?
|
MAP Kinase Signaling System | 1 | 2007 | 1526 | 0.010 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2010 | 2043 | 0.010 |
Why?
|
Physicians | 1 | 2018 | 4567 | 0.010 |
Why?
|
Macrophages | 1 | 2014 | 5655 | 0.010 |
Why?
|
Biopsy | 1 | 2010 | 6756 | 0.010 |
Why?
|
Pilot Projects | 1 | 2011 | 8324 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2013 | 12959 | 0.010 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2017 | 5221 | 0.010 |
Why?
|
Random Allocation | 1 | 2002 | 2429 | 0.010 |
Why?
|
Anti-Inflammatory Agents | 1 | 2007 | 1790 | 0.010 |
Why?
|
Biopsy, Needle | 1 | 2002 | 1641 | 0.010 |
Why?
|
Chronic Disease | 1 | 2011 | 9146 | 0.010 |
Why?
|
Insulin Resistance | 1 | 2009 | 3864 | 0.010 |
Why?
|
Internship and Residency | 1 | 2016 | 5788 | 0.010 |
Why?
|
DNA Repair | 1 | 2005 | 2046 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2015 | 15519 | 0.010 |
Why?
|
Reference Values | 1 | 2002 | 4982 | 0.010 |
Why?
|
Blood Glucose | 1 | 2009 | 6256 | 0.010 |
Why?
|
Dietary Supplements | 1 | 2008 | 3297 | 0.010 |
Why?
|
Insulin | 1 | 2009 | 6580 | 0.010 |
Why?
|
Incidence | 1 | 2011 | 20947 | 0.010 |
Why?
|
United States | 1 | 2020 | 69872 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2003 | 8301 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2013 | 25043 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2008 | 19229 | 0.010 |
Why?
|
Disease Progression | 1 | 2008 | 13284 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 2002 | 18111 | 0.010 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2009 | 11524 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2017 | 77449 | 0.000 |
Why?
|
Time Factors | 1 | 2009 | 40075 | 0.000 |
Why?
|
Adolescent | 1 | 2009 | 85781 | 0.000 |
Why?
|